<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Oing C</dc:creator>
  <dc:creator>Giannatempo P</dc:creator>
  <dc:creator>Honecker F</dc:creator>
  <dc:creator>Oechsle K</dc:creator>
  <dc:creator>Bokemeyer C</dc:creator>
  <dc:creator>Beyer J</dc:creator>
  <dc:date>2018</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Most patients with metastatic germ-cell cancer (GCC) can be cured by cisplatin-based combination chemotherapy. Yet, about 10-15% of metastatic GCC patients will eventually die of their disease. This narrative review focuses on treatment options when cure is no longer realistic.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/278824</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ctrv.2018.10.007</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/30415106</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Cancer treatment reviews. - 2018</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Drug therapy</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Germ cell cancer</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Germ cell tumor</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Palliative treatment</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Platinum-refractory</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Antineoplastic Agents</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Antineoplastic Combined Chemotherapy Protocols</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Bone Neoplasms</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Brain Neoplasms</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Immunotherapy</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Molecular Targeted Therapy</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Neoplasms, Germ Cell and Embryonal</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Palliative Care</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Peripheral Nervous System Diseases</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Psychosocial Support Systems</dc:subject>
  <dc:title xmlns:ns17="xml" ns17:lang="en">Palliative treatment of germ cell cancer.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>